Live feed
·
PRReleasevia Quantisnow
Impel Pharmaceuticals Inc. logo

Impel NeuroPharma to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 24, 2022

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
Impel Pharmaceuticals Inc. logo
IMPL
Impel Pharmaceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2021
Get push alerts for IMPL

Follow IMPL and get a push notification the moment its next story breaks.

Full IMPL profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMPL (Impel Pharmaceuticals Inc.) and more on Quantisnow.